SPARC is a resource navigation tool to enable partner collaboration within a unique open-innovation technology model that integrates capabilities from early stage academic research laboratories with shared-access industry-compliant development facilities and strategic collaborations with market deployment partners.
Successful commercialization of nanobioscience and technologies requires specialized capabilities in multi-disciplines to enable collaboration on material and process, nanofabrication technology and know-how, measurement and test, and translation for healthcare applications.
Driving Nanotechnology Convergence
with Life Science
State of the art heterogeneous integration of nanoelectronics with biomedical platforms
Photonic Integrated Chips
Supply Chain Enablement
Cross disciplinary R & D
R & D Areas
Nano Health and Safety
Cell & Culture Prototype Process
SCOTT TENENBAUM, Ph.D.
Head of Nanobioscience
Dr. Tenenbaum's research focuses on understanding some of the basic aspects of how the human genome works; specifically post-transcriptional gene regulation.
Laboratory of RNA Nanotechnology
The Tenenbaum lab focuses on understanding some of the basic aspects of how the human genome works To do this, they are engineering and using RNA-Nanoswitches. These 4-10nm RNA structures are biological transistors that are being developed for their use in diagnostics, therapeutics, imaging and biomanufacturing.
SUNY Poly Website
Frank Doyle – Bioinformaticist
I rejoined the lab in 2008 to work on the ENCODE project and to develop technologies that I co-invented with Scott and former members of the lab. Among these technologies is sxRNA, which I have advanced beyond concept to a series of functioning synthetic molecular switches.